ekonominyheter

TranslateRSSMobil
Should Johnson & Johnson Buy Medivation Inc.?

Should Johnson & Johnson Buy Medivation Inc.?

Fool.com 12/11 09:55

Johnson & Johnson's top-selling prostate cancer treatment is facing a stiff challenger in Medivation's Xtandi, but an acquisition may not be in the cards.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status